RTM Vital Signs Receives FDA Clearance for its Respiratory Monitoring System (RMS)
Philadelphia, PA — July 22, 2025 — RTM Vital Signs, LLC, a leader in advanced respiratory monitoring, proudly announces that its 1st generation Respiratory Monitoring System (RMS GEN I) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) as a wearable device that continuously measures a patient’s respiratory rate. The RMS GEN […]
Read More